| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/29/2008 | US7365216 Process for the production of citalopram |
| 04/29/2008 | US7365211 Heterocyclic GABAA subtype selective receptor modulators |
| 04/29/2008 | US7365209 Nitrogen heterocycle biaryls for osteoporosis and other diseases |
| 04/29/2008 | US7365200 4-(4-fluoro-benzyl)-5-oxo-7-[4-(thiophene-2-carbonyl)-piperazin-1-yl]-4,5-dihydro-thieno[3,2-b]pyridine-6-carboxylic acid ethyl ester; antitumor, angiogenesis antagonist; antiinflammatoy agent; indirect inhibition of cytokines, growth factors, chemokines, and lymphokines |
| 04/29/2008 | US7365197 Method for the regioselective preparation of substituted benzo[g]quinoline-3-carbonitriles and benzo[g]quinazolines |
| 04/29/2008 | US7365196 Sulphonamido-substituted bridged bicycloalkyl derivatives |
| 04/29/2008 | US7365193 2,7-bis-[(3R)-1-azabicyclo[2.2.2]octan-3-yloxy]-fluoren-9-one; 2,7-bis[(2R)-azetidin-2-ylmethoxy]-fluoren-9-one; alpha 7 Nicotinic acetylcholine receptors ligands; cognitive disorder, neurodegeneration, and neurodevelopmental disorders |
| 04/29/2008 | US7365192 Selective hydrolysis of acarbose, acarbose derivatives with trifluoroacetic acid, removing the byproducts, i.e., monosaccharides, disaccharides, and trisaccharides; purifying valienamine in presence of ion-exchange resins |
| 04/29/2008 | US7365191 immunology; antitumor agents; viricides; anticancer agents; antiinflammatory agents; oligosaccharde containing glucose, galactose, mannose |
| 04/29/2008 | US7365175 Wit 3.0, a novel gene to control soft tissue wound healing |
| 04/29/2008 | US7365174 Azalide and azalactam derivatives and method for producing the same |
| 04/29/2008 | US7365172 Cytoprotective agent to protect a patient undergoing cancer cytotoxic therapy from gastrointestinal side effects; peptide that is derived from a loop or "lollipop" region of transforming growth factor; stimulate hematopoiesis; diabetes, rheumatoid arthritis, lupus, and multiple sclerosis |
| 04/29/2008 | US7365169 T-bet antibodies |
| 04/29/2008 | US7365153 Biologically active peptide and agent containing the same |
| 04/29/2008 | US7365099 Animal body fat control |
| 04/29/2008 | US7365096 Use of amine-substituted cyclododecanone compounds such as 1,3-bis(dimethylaminomethyl)cyclododecan-2-one; Immunosuppressants; transplant rejection, graft versus host disease; fewer side effects than with conventional immunosuppressants |
| 04/29/2008 | US7365095 Chromane and chromene derivatives and uses thereof |
| 04/29/2008 | US7365094 Rheumatic diseases; antiarthritic agents; autoimmune disorders ; antiproliferative agents; antiinflammatory agents; antiprotozoa agents |
| 04/29/2008 | US7365092 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 04/29/2008 | US7365091 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of PHEX |
| 04/29/2008 | US7365090 Substituted phenylindoles for the treatment of HIV |
| 04/29/2008 | US7365089 Triazolo-quinolin derivatives useful as adenosine receptor ligands |
| 04/29/2008 | US7365088 Indazole-derivatives as factor Xa inhibitors |
| 04/29/2008 | US7365087 Oxazole derivatives of tetracyclines |
| 04/29/2008 | US7365086 Pramipexole acid addition salts |
| 04/29/2008 | US7365085 2-(3-{3-[[2-chloro-3-(trifluoromethyl)benzyl](2,2-dephenylethyl)amino]propoxy}phenyl)-ethanol; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption |
| 04/29/2008 | US7365084 Cycloalkyl-substituted amino acid derivatives, processes for their preparation and their use as pharmaceuticals |
| 04/29/2008 | US7365083 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
| 04/29/2008 | US7365082 N-(substituted arylmethyl)-4-(disubstituted methyl)piperidines and piperazines |
| 04/29/2008 | US7365081 Antitumor agents |
| 04/29/2008 | US7365080 Pharmaceutical compositions comprising thieno[2,3-c]pyridine derivatives and use thereof |
| 04/29/2008 | US7365079 2-(2-naphthyl)-4'-[3-oxospiro[6-azaisobenzofuran-1(3H),1-cyclohexan]-4'-yl]-1H-imidazole; metabolic, genitalor reproductive, gastro-intestinal, respiratory system disorders, antiinflammatory agent or glaucoma; cyclization |
| 04/29/2008 | US7365078 Triaza-cyclopenta[cd]indene derivatives |
| 04/29/2008 | US7365077 Obesity, type 2 diabetes, sleep disorders, ischaemic or haemorrhagic strokes, antiemetic; toxicity; side effect reduction; 2-((benzofuran-4-yl)carbonylaminomethyl)-1-((4-(5-(4-fluorophenyl)-2-methyl)thiazolyl)carbonyl)-4-methylpiperazine |
| 04/29/2008 | US7365076 for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders |
| 04/29/2008 | US7365075 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors; potentiation; diabetes and obesity; 2-(4-{4-[1-(6-chloro-pyridin-3-yl)cyclopropylmethyl]-2-(R)-methyl-piperazine-1-sulfonyl}phenyl)-1,1,1-trifluoro-propan-2-ol |
| 04/29/2008 | US7365074 Pyridazine, pyrimidine and pyrazine ethyne compounds |
| 04/29/2008 | US7365073 3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 |
| 04/29/2008 | US7365072 Inhibitors of p38 |
| 04/29/2008 | US7365071 Heterocyclic compounds, preparation process and intermediates, and use as medicaments, in particular as β-lactamase inhibitors and antibacterials |
| 04/29/2008 | US7365070 Such as N-{2-[2-(5-Bromo-2-methoxy-phenyl)-ethyl]-3-fluoro-benzoyl}-N'-butyl-guanidine; involuntary weight loss disorders |
| 04/29/2008 | US7365069 Pyrimidone derivatives |
| 04/29/2008 | US7365068 Hepatitis C virus infections; -(3-cyclopropyl-4-(pentyloxy)phenyl)-3-nicotinoylthiourea;methyl 2-oxo-2-(5-((3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thioureido)carbonyl)pyridin-2-ylamino)acetate |
| 04/29/2008 | US7365067 Neurokinin receptors antagonists; asthma, bronchitis and chronic obstructive lung disease; allergic diseases such as rhinitis, urinary incontinence; 1-(2-{(2R)-2-(3,4dichlorophenyl)-4-[3,5-bis(trifluoromethyl)benzoyl]morpholin-2-yl}ethyl)spiro((2S)-2-{[(morpholin-1-yl)acetyl]oxy})indane-1,4'-piperidine |
| 04/29/2008 | US7365066 Pyrazolopyridine derivatives as pharmaceutical agents |
| 04/29/2008 | US7365065 Antigonadotrophins; Breast and prostate cancer, endometriosis and benign prostate hyperplasia; regulation of fertility; in-vitro fertilisation; oral administration; inexpensive; 3-Amino-4-chloro-N-[4-chloro-5-(2,3-dihydro-benzo[1,4]oxazine-4-carbonyl)-thiophen-3-ylmethyl]-N-methyl-benzenesulfonamide |
| 04/29/2008 | US7365064 Benzoxazine and benzothiazine derivatives and pharmaceutical compositions containing them |
| 04/29/2008 | US7365063 5-HT6 receptor and/or 5-HT2A receptor modulators; CNS disorders such as Parkinson's disease, Huntington's disease, anxiety, depression, manic depression, psychoses, epilepsy, obsessive compulsive disorders, mood disorders, migraine, Alzheimer's disease, sleep disorders, feeding disorders |
| 04/29/2008 | US7365062 4-(2-fluorophenylbenzoyl-4-aminobenzoyl)-3'-(2-(N,N-dimethylaminoethylaminocarbonyl))-4-aza-[6,4]-spiro-[5,6]-benzoundec-2'-ene; hypertension, congestive heart failure, cardiac insufficiency, coronary vasospasm, cardiac ischemia, liver cirrhosis, renal vasospasm, renal failure, cerebral edema or ischemia |
| 04/29/2008 | US7365061 Antidiabetic agents, anticancer, non-cardiac ischemia, infection, hypertension, obesity and dislipidemia; 3-(5-chloroindole-2-carbonylamino)-2-hydroxy-1,2,3,4-tetrahydronaphthalene |
| 04/29/2008 | US7365060 Dinuclear copper-based compound and ligand for nucleic acid scission and anticancer treatment |
| 04/29/2008 | US7365059 Photocrosslinked-polysaccharide composition and production process of the same |
| 04/29/2008 | US7365057 Treating hepatitis C virus infections; antivirals have low toxicity to the host; inhibit Flaviviridae polymerase |
| 04/29/2008 | US7365056 Substituted 9a-N-(N′-(sulfonyl)phenylcarbamoyl)derivatives of 9-deoxo-9-dihydro-9a-aza-9a-homoerithomycin A and 5-0-desosaminyl-9-deoxo-9-dihydro-9-a-aza-9a-homoerithronolide A |
| 04/29/2008 | US7365055 Derivatives of morphine-6-glucuronide, pharmaceutical compositions containing them, their preparation method and their uses |
| 04/29/2008 | US7365050 Using calcium channel blockers |
| 04/29/2008 | US7365049 Afamin-containing compositions and methods of use |
| 04/29/2008 | US7364919 Immobilization carbohydrates; calibration; diagnosis; antiinflammatory agents, bactericides |
| 04/29/2008 | US7364910 Methods of inducing ovulation |
| 04/29/2008 | US7364888 Intratracheal administration of lysozyme with other therapeutic agents in the prevention and treatment of respiratory disorders |
| 04/29/2008 | US7364880 Reusing hydrochloric, sulfuric or phosphoric acid in hydrolysis of fungal biomass and generation of glucosamine and citric acid; bioreactors |
| 04/29/2008 | US7364864 ANGE gene in atopy |
| 04/29/2008 | US7364847 nucleic acid that binds to high mobility group protein-I (HMG-I), and causes presenilin-2 gene exon 5-lacked type aberrant splicing by the association with the HMG-I protein; an inhibitor for inhibiting a binding between protein-nucleic acid caused by aberrant splicing; drug screening; antisense agents |
| 04/29/2008 | US7364764 Soluble roasted chicory having high inulin content |
| 04/29/2008 | US7364759 topically applying to the skin a formulation containing an extract of black cohosh obtained by exposing the black cohosh to two or more solvents of varying solvent strengths for suppressing melanogenesis |
| 04/29/2008 | US7364756 Anti-virus hydrophilic polymeric material |
| 04/29/2008 | US7364754 Preparing micelles entrapping photosensitive drugs; adding alkoxyorganosilane to the micelles to form complexes of silica and the micelles; subjecting the complexes of silica and micelles to alkaline hydrolysis to precipitate silica nanoparticles; isolating the precipitated nanoparticles by dialysis |
| 04/29/2008 | US7364752 Solid dispersion pharamaceutical formulations |
| 04/29/2008 | US7364751 By adding an antioxidant and/or a chelating agent in the same aqueous solution; reduced coenzyme Q10, vitamin C and ethylenediaminetetracetic acid for example |
| 04/29/2008 | US7364749 Preventing scar tissue formation on the trachea, bonchi or alveoli by administering liposomes containing povidone iodine along with an antiinflammatory agent, anesthetic, antioxidant, antibiotic, or corticoid |
| 04/29/2008 | US7364746 Based on 3-iodo-2-propynyl butylcarbamate (IPBC), a liquid carrier and a stabilizer; free of benzoic acid, propionic acid, salicylic acid, sorbic acid, 4-hydroxybenzoic acid, dehydroacetic acid and 10-undecylenic acid |
| 04/29/2008 | US7364736 Immmunoglobulin which prevents binding of osteoprotegerin ligand (OPGL) to osteoclast differentiation and activation receptor (ODAR) for treatment and prevention of bone, inflammatory, arthritic and autoimmune disorders |
| 04/29/2008 | US7364725 Endothelial cells engineered to express or overexpress fibulin-5 and a growth factor |
| 04/29/2008 | US7364723 Liquid preparation for contact lenses |
| 04/29/2008 | US7364719 Vasoregulating compounds and methods of their use |
| 04/29/2008 | US7364576 Method and assembly for treating pain of liquid nitrogen therapy |
| 04/29/2008 | US7363928 Hyaluronate-based viscoelastic agent and low viscosity, chondroitin sulfate and hydroxypropylmethylcellulose-containing solution; for use in intr-articular therapy and as vitreous replacement in vitreo-retinal surgery |
| 04/29/2008 | CA2425494C Process for making 3-amino-2-chloro-4-methylpyridine |
| 04/29/2008 | CA2406798C Pharmaceutical parenteral composition containing a biphosphonate |
| 04/29/2008 | CA2394037C New derivatives of benzene sulfonamide, their preparation process and pharmaceutical compositions that contain them |
| 04/29/2008 | CA2363317C Novel process for preparing alendronic acid |
| 04/29/2008 | CA2343204C Arylsulfonanilide ureas |
| 04/29/2008 | CA2338776C Novel c-2 s/o- and s/n formaldehyde acetal derivatives of carbapenem-3-carboxylic acids and their use as antibiotics and .beta.-lactamase inhibitors |
| 04/29/2008 | CA2336474C C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 04/29/2008 | CA2321461C Cross-linked high amylose starch having functional groups as a matrix for the slow release of pharmaceutical agents |
| 04/29/2008 | CA2321188C Derivatives of azetidine and pyrrolidine |
| 04/29/2008 | CA2315329C Improved hmg coa reductase inhibitor extended release formulation |
| 04/29/2008 | CA2312990C Novel salts of metformin and method |
| 04/29/2008 | CA2309178C Topical compositions for nsai drug delivery |
| 04/29/2008 | CA2305331C Methods for decreasing the frequency of transmission of viral and for preventing and treating bacterial infections using cellulose acetate phthalate or hyroxypropyl methylcellulose phthalate excipients |
| 04/29/2008 | CA2304712C Endothelin antagonist and a renin-angiotensin system inhibitor as a combined preparation |
| 04/29/2008 | CA2302445C New taxane derivatives |
| 04/29/2008 | CA2297756C Methods of pretreating hyperlipidemic individuals with a flush inhibiting agent prior to the start of single daily dose nicotinic acid therapy to reduce flushing provoked by nicotinic acid |
| 04/29/2008 | CA2297732C Heterocyclic vinylethers against neurological disorders |
| 04/29/2008 | CA2294756C Cross-linked polysaccharide drug carrier |
| 04/29/2008 | CA2272711C Method for treating renal failure |
| 04/29/2008 | CA2271944C Formulation for electrically assisted delivery of lidocaine and epinephrine |
| 04/29/2008 | CA2268957C Immune response modifier compounds for treatment of th2 mediated and related diseases |
| 04/29/2008 | CA2259960C Down-regulation of dna repair to enhance sensitivity to p53-mediated suppression |
| 04/29/2008 | CA2254833C Pharmaceutical for treatment of neurological and neuropsychiatric disorders |